AI in Cancer Care: Separating Fact from Fiction
The CPC and CBEx Annual Congress, on October 6-8, creates an interactive environment for cancer care stakeholders to explore and share practical approaches to relevant issues.
CBEx Advisory Board Member Ira Klein, MD, VP of Medical Affairs for Tempus Labs, provides an inside look into featured session "AI in Cancer Care: Separating Fact from Fiction."
Watch the video to learn more about this session and how this esteemed panel will separate the hype from the reality using real-life case scenarios to break down what you need to know about AI.
Register today to improve your knowledge about AI, how it works, and how it can be harnessed to benefit cancer care.
Transcript:
Dr Ira Klein: Hi, this is Dr Ira Klein, vice president, Medical Affairs for Tempus Labs. Here to talk to you about the upcoming CBEx and CPC conference. We'll be doing a presentation on artificial intelligence and AI and cancer care, separating fact from fiction.
When you get to the presentation, we're going to be talking about how to gain greater knowledge of what artificial intelligence is, how it works, how it can be harnessed to benefit cancer care. Included in the presentation, we're going to tell you some technical descriptions of AI, the components therein, and some examples and scenarios and applications that we think will help dispel the hype from the reality and show where the true opportunities reside, as well as the future opportunities and possibilities.
We have a great set of panelists for you to talk to. We're going to have examples of natural language processing, general uses in the public space, and specifically, a drill down on healthcare interoperability, and data exchange.
And we're going to get into some case studies that go to data science and algorithms, other applications, as well as clinical studies beyond the typical ones you might think of.
We're also going to talk about the present and future AI products. And we're going to talk about how you intake the data, what it looks like, how you do the permissioning, some of the regulatory policy issues that you have to deal with, and then, what is it that you might not think of that others are working on today in AI, including some of the practical and mundane issues regarding prior authorization, pre-certification. And we're going to end the panel with a great discussion about clinical oncology pathways, what does that mean as guidance at the individual point of care versus general guidance? So, we're super excited to have you there.
We think that a lot of what's going on in the AI world is very exciting. We want to be able to tell you what is structured AI versus unstructured AI, how generative AI is powered by foundation models, what neural networks do, what ChatGPT means. Hint, it's generative, pre-trained transformer.
And then, we're going to be able to talk to you and get your questions from us about what goes on with that training called deep learning. And that's a term that alludes to the many deep layers within the neural network.
So, we hope that this topic and this presentation will bring to you the importance and the relevance of AI in the world that you live in today. Because whether you're a practitioner taking care of patients, a backend office support person who's managing the mountains of data that the practice has, whether you are on the payer side managing requests for services, whether you're on the intermediary side managing the data, managing specific types of services. And particularly, if you're on the pharmaceutical industry side, you need to know about artificial intelligence, machine learning, natural language processing, and how this is all fed with the big data engine.
So, it sounds like it's going to be a great topic. And I just want to say that we hope to see you in October at the CPC and CBEx meeting, because we're going to have more than 400 cancer care professionals gathering in Boston. And that's the place to be for practical strategies as well as insights into how we're developing and delivering what people are paying for, and how they're making it happen in the care industry.